Skip to main content
. 2025 Sep 1;25(1):312. doi: 10.1007/s10238-025-01855-0

Table 1.

KRT18 expression correlates with clinicopathological features (chi-square test)

Characteristics Low expression of KRT18 High expression of KRT18 P value
n 269 270
Pathologic T-stage, n (%) 0.012
T1 102 (19%) 74 (13.8%)
T2 140 (26.1%) 152 (28.4%)
T3 16 (3%) 33 (6.2%)
T4 9 (1.7%) 10 (1.9%)
Pathologic N-stage, n (%) 0.018
N0 181 (34.6%) 169 (32.3%)
N1 49 (9.4%) 48 (9.2%)
N2 25 (4.8%) 49 (9.4%)
N3 2 (0.4%) 0 (0%)
Pathologic M stage, n (%) 0.626
M0 179 (45.9%) 186 (47.7%)
M1 11 (2.8%) 14 (3.6%)
Pathologic stage, n (%) 0.027
Stage I 162 (30.5%) 134 (25.2%)
Stage II 58 (10.9%) 67 (12.6%)
Stage III 31 (5.8%) 53 (10%)
Stage IV 12 (2.3%) 14 (2.6%)
Gender, n (%) 0.180
Female 152 (28.2%) 137 (25.4%)
Male 117 (21.7%) 133 (24.7%)
Age, n (%) 0.725
 <  = 65 126 (24.2%) 131 (25.2%)
 > 65 133 (25.6%) 130 (25%)
Smoker, n (%) 0.113
No 45 (8.6%) 32 (6.1%)
Yes 218 (41.5%) 230 (43.8%)
Number pack years smoked, n (%) 0.652
 < 40 87 (23.6%) 101 (27.4%)
 >  = 40 88 (23.8%) 93 (25.2%)

All content highlighted in bold in the tables indicates that the corresponding p-values meet the criterion of statistical significance (i.e., p<0.05).